Variation in HLA class I antigen-processing genes and susceptibility to human papillomavirus type 16-associated cervical cancer

Journal of Infectious Diseases

Volumn 197, Issue 3, 2008, Pages 371-381

  Deshpande, Alina ^a   Wheeler, Cosette M ^b,d   Hunt, William C ^b   Peyton, Cheri L ^b   White, P Scott ^a   Valdez, Yolanda E ^a   Nolan, John P ^a,c  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^c LA JOLLA BIOENGINEERING INSTITUTE   (United States)

^d UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; LARGE MULTIFUNCTIONAL PROTEASOME 2; LARGE MULTIFUNCTIONAL PROTEASOME 7; PROTEASOME; TAPASIN; TAPASIN 1; TAPASIN 2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; FEMALE; FLOW CYTOMETRY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HISPANIC; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX CANCER;

ATP-BINDING CASSETTE TRANSPORTERS; CASE-CONTROL STUDIES; CYSTEINE ENDOPEPTIDASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMAN PAPILLOMAVIRUS 16; HUMANS; MEMBRANE TRANSPORT PROTEINS; MULTIENZYME COMPLEXES; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN CONFORMATION; REFERENCE VALUES; UTERINE CERVICAL NEOPLASMS; VARIATION (GENETICS);

EID: 39349100876     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/524300     Document Type: Article

References (50)

1. Bauer HM, Ting Y, Greer CE, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991; 265:472-7.
2. Ho GY, Burk RD, Klein S, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995; 87:1365-71.
3. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12-9.
4. Groettrup M, Standera S, Stohwasser R, Kloetzel PM. The subunits MECL-1 and LMP2 are mutually required for incorporation into the 20S proteasome. Proc Natl Acad Sci USA 1997; 94:8970-5.
5. Griffin TA, Nandi D, Cruz M, et al. Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits. J Exp Med 1998; 187:97-104.
6. Fruh K, Yang Y. Antigen presentation by MHC class I and its regulation by interferon gamma. Curr Opin Immunol 1999; 11:76-81.
7. Androlewicz MJ, Anderson KS, Cresswell P. Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. Proc Natl Acad Sci USA 1993; 90:9130-4.
8. Neefjes JJ, Momburg F, Hammerling GJ. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science 1993; 261:769-71.
9. Sadasivan B, Lehner PJ, Ortmann B, Spies T, Cresswell P. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 1996; 5:103-14.
10. Garcia AM, Ortiz-Navarrete VF, Mora-Garcia ML, et al. Identification of peptides presented by HLA class I molecules on cervical cancer cells with HPV-18 infection. Immunol Lett 1999; 67:167-77.
11. Wang SS, Wheeler CM, Hildesheim A, et al. Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica. J Infect Dis 2001; 184:1310-4.
12. Cuzick J, Terry G, Ho L, et al. Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women. Br J Cancer 2000; 82:1348-52.
13. Maciag PC, Schlecht NF, Souza PSA, Franco EL, Villa LL, Petzl-Erler ML. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women. Cancer Epidemiol Biomarkers Prev 2000; 9:1183-91.
14. Madeleine MM, Brumback B, Cushing-Haugen KL, et al. Human leukocyte antigen class II and cervical cancer risk: a population-based study. J Infect Dis 2002; 186:1565-74.
15. Heward JM, Allahabadia A, Sheppard MC, Barnett AH, Franklyn JA, Gough SC. Association of the large multifunctional proteasome (LMP2) gene with Graves' disease is a result of linkage disequilibrium with the HLA haplotype DRB1*0304-DQB1*02-DQA1*0501. Clin Endocrinol (Oxf) 1999; 51:115-8.
16. Maksymowych WP, Tao S, Vaile J, Suarez-Almazor M, Ramos-Remus C, Russell AS. LMP2 polymorphism is associated with extraspinal disease in HLA-B27 negative Caucasian and Mexican Mestizo patients with ankylosing spondylitis. J Rheumatol 2000; 27:183-9.
17. Martin-Villa JM, Martinez-Laso J, Moreno-Pelayo MA, et al. Differential contribution of HLA-DR, DQ, and TAP2 alleles to systemic lupus erythematosus susceptibility in Spanish patients: role of TAP2*01 alleles in Ro autoantibody production. Ann Rheum Dis 1998; 57:214-9.
18. Ma L, Penfornis A, Wang X, et al. Evaluation of TAP1 polymorphisms with insulin dependent diabetes mellitus in Finnish diabetic patients. Hum Immunol 1997; 53:159-66.
19. Rau H, Nicolay A, Donner H, Usadel KH, Badenhoop K. Polymorphisms of TAP1 and TAP2 genes in German patients with type 1 diabetes mellitus. Eur J Immunogenet 1997; 24:229-36.
20. Hjelmstrom P, Giscombe R, Lefvert AK, et al. TAP polymorphisms in Swedish myasthenia gravis patients. Tissue Antigens 1997; 49:176-9.
21. Gostout BS, Poland GA, Calhoun ES, et al. TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer risk. Gynecol Oncol 2003; 88:326-32.
22. Kaderali L, Deshpande A, Nolan JP, White PS. Primer-design for multiplexed genotyping. Nucleic Acids Res 2003; 31:1796-1802.
23. Ewing B, Hillier L, Wendl MC, Green P. Base-calling of automated sequencer traces using Phred. I. Accuracy assessment. Genome Res 1998; 8:175-85.
24. Ewing B, Green P. Base-calling of automated sequencer traces using Phred. II. Error probabilities. Genome Res 1998; 8:186-94.
25. Nickerson DA, Tobe VO, Taylor SL. PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res 1997; 25:2745-51.
26. Greer CE, Wheeler CM, Manos MM. Sample preparation and PCR amplification from paraffin-embedded tissues. PCR Methods Appl 1994; 3:S113-22.
27. Peyton CL, Gravitt PE, Hunt WC, et al. Determinants of genital human papillomavirus detection in a US population. J Infect Dis 2001; 183:1554-64.
28. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998; 36:3020-7.
29. Deshpande A, Nolan JP, White PS, et al. TNF-α promoter polymorphisms and susceptibility to HPV16-associated cervical cancer. J Infect Dis 2005; 191:969-76.
30. Deshpande A, Valdez Y, Nolan JP. Multiplexed SNP genotyping using primer single-base extension (SBE) and microsphere arrays. Unit 13.4 in: Robinson JP, Darzynkiewicz Z, Hoffman R, et al., eds. Current protocols in cytometry 2005, supplement 34. New York: John Wiley & Sons, 2005.
31. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002; 70:425-34.
32. Fredman D, Siegfried M, Yuan YP, Bork P, Lehväslaiho H, Brookes AJ. HGVbase: a human sequence variation database emphasizing data quality and a broad spectrum of data sources. Nucleic Acids Res 2002; 30:387-91.
33. Cullen M, Perfetto SP, Klitz W, Nelson G, Carrington M. High-resolution patterns of meiotic recombination across the human major histocompatibility complex. Am J Hum Genet 2002; 71:759-76.
34. Cullen M, Erlich H, Klitz W, Carrington M. Molecular mapping of a recombination hotspot located in the 2nd intron of the human TAP2 locus. Am J Hum Genet 1995; 56:1350-8.
35. Nijenhuis M, Schmitt S, Armandola EA, Obst R, Brunner J, Hammerling GJ. Identification of a contact region for peptide on the TAP1 chain of the transporter associated with antigen processing. J Immunol 1996; 156:2186-95.
36. Nijenhuis M, Hammerling GJ. Multiple regions of the transporter associated with antigen processing (TAP) contribute to its peptide binding site. J Immunol 1996; 157:5467-77.
37. Kammerer S, Burns-Hamuro LL, Ma YL, et al. Amino acid variant in the kinase-binding domain of dual-specific A kinase-anchoring protein 2: a disease susceptibility polymorphism. Proc Natl Acad Sci USA 2003; 100:4066-71.
38. Quadri SA, Singal DP. Peptide transport in human lymphoblastoid and tumor cells: effect of transporter associated with antigen presentation (TAP) polymorphism. Immunol Lett 1998; 61:25-31.
39. Bouvier M. Accessory proteins and the assembly of human class I MHC molecules: a molecular and structural perspective. Mol Immunol 2003; 39:697-706.
40. Tang J, Freedman DO, Allen S, et al. Genotyping TAP2 variants in North American Caucasians, Brazilians and Africans. Genes Immun 2001; 2:32-40.
41. Hildesheim A, Wang SS. Host and viral genetics and risk of cervical cancer: a review. Virus Res 2002; 89:229-40.
42. Kauppi L, Sajantila A, Jeffreys AJ. Recombination hotspots rather than population history dominate linkage disequilibrium in the MHC class II region. Hum Mol Genet 2003; 12:33-40.
43. Jeffreys AJ, Kauppi L, Neumann R. Intensely punctate meiotic recombination in the class II region of the major histocompatibility complex. Nature Genet 2001; 29:217-22.
44. Van Endert PM, Lopez MT, Patel SD, Monaco JJ, McDevitt HO. Genomic polymorphism, recombination, and linkage disequilibrium in human major histocompatibility complex-encoded antigen-processing genes. Proc Natl Acad Sci USA 1992; 89:11594-7.
45. Klitz W, Stephens JC, Grote M, Carrington M. Discordant patterns of linkage disequilibrium of the peptide-transporter loci within the HLA class II region. Am J Hum Genet 1995; 57:1436-44.
46. Kumagai S, Kanagawa S, Morinobu A, et al. Association of a new allele of the TAP2 gene, TAP2*BKY2 (Val 577), with susceptibility to Sjogren's syndrome. Arthritis Rheum 1997; 40:1685-92.
47. Ishihara M, Ohno S, Ishida T, et al. Analysis of allelic variation of the TAP2 gene in sarcoidosis. Tissue Antigens 1997; 49:107-10.
48. Carrington M, Stephens JC, Klitz W, Begovich AB, Erlich HA, Mann D. Major histocompatibility complex class II haplotypes and linkage disequilibrium values observed in the CEPH families. Hum Immunol 1994; 41:234-40.
49. Djilali-Saiah I, Benini V, Daniel R, Assan J, Bach JF, Caillat-Zucman S. Linkage disequilibrium between HLA class II (DR, DQ, DP) and antigen processing (LMP, TAP, DM) genes of the major histocompatibility complex. Tissue Antigens 1996; 48:87-92.
50. Tuokko J, Nejentsev S, Luukkainen R, Toivanen A, Ilonen J. HLA haplotype analysis in Finnish patients with rheumatoid arthritis. Arthritis Rheum 2001; 44:315-22.